We are building a spare change investment platform to help you invest in companies working on a cure for Alzheimer’s.
Yet, most major pharmaceuticals have cut back on Alzheimer’s R&D as unprofitable, while smaller scientist led companies are left struggling for investment to develop promising scientific discoveries into a cure.
Alzheimer’s can be reversed in mice and many pathways to a cure have been discovered
Investment in companies working on a cure is scarce, stifling progress
A spare change investment platform to help millions invest in companies working on a cure for Alzheimer’s
InvestAcure has developed a formidable plan to end the roadblock imposed by insufficient capital to fund clinical trials necessary to discover effective cures for Alzheimer Disease. With so many major pharmaceutical companies leaving the space, it is even more imperative that we activate this approach immediately if we are to bring cures to families.
We can cure Alzheimer’s in our mice every week, but when it comes to clinical research where real progress needs to be made to cure people, there is simply no funding available.
We can't afford to sit idly by as research is stalled by a profit-driven agenda. With InvestAcure, we have a real solution to speed the path to a cure, by transitioning ownership of drug companies to millions of spare change investors committed to curing Alzheimer's.
Automatically round up transactions and invest just spare change in a portfolio of companies chosen by leading scientists
Set up your InvestAcure investment account online and connect your credit cards
Spend like normal. Your day-to-day transactions are rounded up to the nearest dollar and set aside for investment
With the guidance of leading scientists, your spare change is invested in companies working on a cure for Alzheimer's
When drug companies are owned by millions of spare change investors committed to curing Alzheimer's....
Seventy million Americans have a relative with Alzheimer's - every million spare change investors can mean $3 billion in investment over 5 years!
That would have 30X the impact of Bill Gates' recently publicized $100 million commitment to Alzheimer's research.
Your spare change will be invested in a portfolio of companies, chosen with the guidance of leading Alzheimer's researchers, based on their potential contribution to advancing the development of a cure.